References
- Irvin R G, Cobb F R, Roe C R. Acute myocardial infarction and MB creatine Phosphokinase. Relationship between onset of symptoms of infarction and appearance and disappearance of enzyme. Arch Intern Med 1980; 140: 329–34
- Lott J A, Stang J M. Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem 1980; 26: 1241–50
- Elser R C, McKenna K. Creatine kinase B-subunit activity in human sera: Temporal aspects of its sensitivity after myocardial infarction. Clin Chem 1981; 27: 57–60
- Werner M, Brooks S H, Mohrbacher R J, Wasserman A G. Diagnostic performance of enzymes in the discrimination of myocardial infarction. Clin Chem 1982; 28: 1297–302
- Fisher M L, Carliner N H, Becker L C, Peters R W, Plotnick G D. Serum creatine kinase in the diagnosis of acute myocardial infarction. Optimal sampling frequency. JAMA 1983; 249: 393–4
- Sobel B E, Markham J, Karlsberg R P, Roberts R. The nature of disappearance of creatine kinase from the circulation and its influence on enzymatic estimation of infarct size. Circ Res 1977; 41: 836–43
- Wevers R A, Delsing M, Gebbink J AG Klein, Soons J BJ. Postsynthetic changes in creatine kinase isoenzymes (EC 2.7.3.2). Clin Chim Acta 1978; 86: 323–7
- Chapelle J P, Heusghem C. Further heterogeneity demonstrated for serum creatine kinase isoenzyme MM. Clin Chem 1980; 26: 457–62
- Falter H, Michelutti L, Mazzuchin A, Whiston W. Studies on the sub-banding of creatine kinase MM and the ‘CK conversion factor’. Clin Biochem 1981; 14: 3–7
- Yasmineh W G, Yamada M K, Cohn J N. Postsynthetic variants of creatine kinase MM. J Lab Clin Med 1981; 98: 109–18
- George S, Ishikawa Y, Perryman M B, Roberts R. Purification and characterization of naturally occurring and in vitro induced multiple forms of MM creatine kinase. J Biol Chem 1984; 259: 2667–74
- Hashimoto H, Grace A M, Billadello J J, Gross R W, Strauss A W, Sobel B E. Nondenaturing quantification of subforms of canine MM creatine kinase isoenzymes (isoforms) and their intercon-version. J Lab Clin Med 1984; 103: 470–84
- Perryman M B, Knell J D, Roberts R. Carboxy peptidase-catalyzed hydrolysis of C-terminal lysine: Mechanism for in vivo production of multiple forms of creatine kinase in plasma. Clin Chem 1984; 30: 662–4
- Morelli R L, Carlson C J, Emilson B, Abendschein D R, Rapaport E. Serum creatine kinase MM isoenzyme sub-bands after acute myocardial infarction in man. Circulation 1983; 67: 1283–9
- Chapelle J P. Serum creatine kinase MM sub-band determination by isoelectric focusing: A potential method for the monitoring of myocardial infarction. Clin Chim Acta 1984; 137: 273–81
- Panteghini M, Cuccia C, Malchiodi A, Leonzi O, Pagnoni N. Postsynthetic variants of creatine kinase MM and MB in acute myocardial infarction. Eur Heart J 1984; 5(Suppl. 1)136
- Panteghini M, Cuccia C, Malchiodi A, Calarco M, Pagnoni N. Isoforms of creatine kinase MM and MB in acute myocardial infarction: A clinical evaluation. Clin Chim Acta 1986; 155: 1–10
- Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979; 59: 607–9
- The Committée on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. Scand J Clin Lab Invest 1979; 39: 1–5
- Armitage P. Statistical Methods in Medical Research. Wiley, New York 1971
- Norris R M, Whitlock R ML, Barratt-Boyes C, Small C W. Clinical measurement of myocardial infarct size. Circulation 1975; 51: 614–20
- Sobel B E, Bresnahan G F, Shell W E, Yoder R D. Estimation of infarct size in man and its relation to prognosis. Circulation 1972; 46: 640–8
- Annesley T M, Strongwater S L, Schnitzer T J. MM subisoenzymes of creatine kinase as an index of disease activity in polymyositis. Clin Chem 1985; 31: 402–6